CellaVision AB represents a set of core values and a corporate philosophy that underpin its operations. The company is committed to excellence, innovation, and customer satisfaction. Through its cutting-edge technologies and solutions, CellaVision aims to revolutionize hematology analysis and improve patient care. With a focus on quality, CellaVision strives to deliver accurate and reliable results, empowering healthcare professionals worldwide. Moreover, the company fosters a culture of collaboration, teamwork, and transparency to drive advancements in the field of medical diagnostics. By embodying these values, CellaVision AB remains dedicated to its mission of transforming healthcare through intelligent automation and efficient laboratory workflows.

CellaVision AB is primarily present in various countries and regions around the world. With its global reach, the company has established its presence in countries such as Sweden, the United States, and various European and Asian markets. CellaVision AB's extensive global footprint allows it to cater to a diverse customer base and expand its market share internationally.

CellaVision AB, a renowned company in the stock market, has achieved several significant milestones throughout its journey. These include the development and launch of cutting-edge hematology analyzers, such as the CellaVision DM96 and CellaVision DC-1. The company has also expanded its global presence, establishing strategic partnerships with various leading healthcare organizations worldwide. Furthermore, CellaVision AB has consistently demonstrated its commitment to innovation by continuously enhancing its product portfolio and introducing advanced digital solutions in the field of automated blood and body fluid analysis. With its relentless pursuit of excellence and industry recognition, CellaVision AB stands as a remarkable player in the stock market.

CellaVision AB is a leading global provider of advanced digital solutions for medical microscopy in the field of hematology. Founded in 1994, CellaVision has a rich history in developing and supplying innovative products that revolutionize the analysis of blood and other body fluids. The company's breakthrough technologies enable automated digital microscopy, accelerating and improving the diagnostic workflow in clinical laboratories. CellaVision's solutions offer healthcare professionals increased efficiency, accuracy, and patient safety, ultimately contributing to better healthcare outcomes. With a strong commitment to research and development, CellaVision continues to pioneer advancements in digital hematology, establishing itself as a trusted name in the industry.

The main competitors of CellaVision AB in the market include Sysmex Corporation, Roche Diagnostics, and Beckman Coulter.

CellaVision AB is primarily active in the medical technology industry.

The business model of CellaVision AB focuses on developing and selling digital solutions for medical laboratories worldwide. CellaVision offers an innovative range of products, including automated digital systems for advanced blood cell analysis and software solutions for efficient lab management. The company's solutions aim to improve lab productivity, quality, and patient care by streamlining workflow processes and enhancing the accuracy of blood cell analysis. CellaVision AB stands as a leading provider in the field of hematology diagnostics, enabling healthcare professionals to make better-informed decisions for optimizing patient outcomes.

لا يمكن حساب مضاعف الربحية للسهم لـCellaVision في الوقت الحالي.

لا يمكن حالياً حساب معامل القيمة السوقية إلى العائدات لـ CellaVision.

نقاط جودة AlleAktien لـ CellaVision هي 9/10.

المتوقعة CellaVision الإيرادات هي ٨٠٠٫٩٦ مليون. SEK.

صافي الربح المتوقعة CellaVision هو ١٧٣٫٧٧ مليون. SEK.

CellaVision AB is a leading provider of digital solutions for automated blood cell analysis. The company, based in Lund, Sweden, was founded in 1994 and now employs over 350 people.

يوزع CellaVision أرباحًا قدرها ٢٫٠٠ SEK من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ CellaVision في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـCellaVision هو SE0000683484.

رمز WKN لـ CellaVision هو A0NEVD.

الرمز المُختصر لـ CellaVision هو CEVI.ST.

خلال آخر 12 شهراً، دفعت CellaVision توزيعات أرباح بقيمة ٢٫٢٥ SEK . وهذا يعادل عائد توزيعات أرباح يقارب . ومن المتوقع أن تدفع CellaVision خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٢٫٥٤ SEK.

نسبة توزيعات الأرباح الحالية لـ CellaVision هي .

CellaVision يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر يونيو, يونيو, يونيو, يونيو.

CellaVision دفعت توزيعات الأرباح كل عام خلال الـ0 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٢٫٥٤ SEK. وهذا يعادل عائد توزيعات أرباح قدره ١٫٣٠ %.

CellaVision يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ٢٫٥ SEK من CellaVision المُعلن عنها في ١٣‏/٥‏/٢٠٢٥، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٧‏/٥‏/٢٠٢٥.

تم توزيع آخر دفعة من الأرباح بتاريخ ١٣‏/٥‏/٢٠٢٥.

في العام 2024، وزعت CellaVision ٢٫٢٥ SEK كأرباح أسهم.

يتم توزيع أرباح CellaVision بالعملة SEK.